These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 721057)

  • 61. Letter: Hypotension during angiotensin blockade with saralasin.
    Pettinger WA; Keeton K
    Lancet; 1975 Jun; 1(7921):1387-8. PubMed ID: 48980
    [No Abstract]   [Full Text] [Related]  

  • 62. Clinical use of angiotensin blocking agents.
    Case DB
    N Y State J Med; 1977 Nov; 77(13):2100-4. PubMed ID: 200867
    [No Abstract]   [Full Text] [Related]  

  • 63. Converting enzyme inhibition in hypertensive emergencies.
    Tifft CP; Gavras H; Kershaw GR; Gavras I; Brunner HR; Liang CS; Chobanian AV
    Ann Intern Med; 1979 Jan; 90(1):43-7. PubMed ID: 420460
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Concept of anti-renin system therapy. Historic perspective.
    Laragh JH
    Am J Med; 1984 Aug; 77(2A):1-6. PubMed ID: 6383032
    [No Abstract]   [Full Text] [Related]  

  • 65. [Variable action of central and peripheral angiotensin II blockade in genetic hypertension in rats].
    Mann JF; Phillips MI; Dietz R; Haebara H; Lüth JB; Ganten D
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():189-90. PubMed ID: 613564
    [No Abstract]   [Full Text] [Related]  

  • 66. Enzyme inhibitor therapy of hypertension.
    Prosnitz EH
    Ariz Med; 1979 Apr; 36(4):286-8. PubMed ID: 220936
    [No Abstract]   [Full Text] [Related]  

  • 67. [A review of hypertension with hypopotassemia (author's transl)].
    Koang AK
    Zhonghua Nei Ke Za Zhi; 1979; 18(1):65-70. PubMed ID: 399451
    [No Abstract]   [Full Text] [Related]  

  • 68. Converting-enzyme inhibition and glomerular filtration rate in essential hypertension.
    Bianchi MD; Fernandes M
    N Engl J Med; 1980 Jan; 302(3):179. PubMed ID: 6243169
    [No Abstract]   [Full Text] [Related]  

  • 69. Treatment of patients with severe hypertension by inhibition of angiotensin-converting enzyme.
    Johnson JG; Black WD; Vukovich RA; Hatch FE; Friedman BI; Blackwell CF; Shenouda AN; Share L; Shade RE; Acchiardo SR; Muirhead EE
    Clin Sci Mol Med Suppl; 1975 Jun; 2():53s-56s. PubMed ID: 1077791
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The use of angiotensin-converting enzyme inhibitor in the diagnosis and treatment of hypertension.
    Gavras H; Brunner HR; Laragh JH; Gavras I; Vukovich RA
    Clin Sci Mol Med Suppl; 1975 Jun; 2():57s-60s. PubMed ID: 1077792
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Use of continuous saralasin infusion to control hypertension.
    Ruley EJ; Bock GH; Smith D
    J Pediatr; 1982 Dec; 101(6):1013-7. PubMed ID: 7143155
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Newer concepts in antihypertensive drugs.
    Frohlich ED
    Prog Cardiovasc Dis; 1978; 20(5):385-402. PubMed ID: 635215
    [No Abstract]   [Full Text] [Related]  

  • 73. Angiotensin converting enzyme inhibition: a new therapeutic modality.
    Gavras H; Charocopos F; Brunner H; Gavras I
    Bull N Y Acad Med; 1981 May; 57(4):304-10. PubMed ID: 6164426
    [No Abstract]   [Full Text] [Related]  

  • 74. The role of hormones in congestive heart failure: new frontiers in therapy?
    Turini GA; Brunner HR
    Clin Sci (Lond); 1982 Oct; 63(4):333-8. PubMed ID: 6179686
    [No Abstract]   [Full Text] [Related]  

  • 75. Intrarenal formation of angiotensin II in the rat: interference by Saralasin and SQ 20881.
    Zschiedrich H; Hofbauer KG; Hackenthal E; Baron GD; Gross F
    Clin Sci Mol Med Suppl; 1975 Jun; 2():37s-40s. PubMed ID: 1077787
    [No Abstract]   [Full Text] [Related]  

  • 76. [Clinical application of an angiotensin II analogue (ii). Blood pressure changes following the infusion of 1-sarcosine. 8-isoleucine angiotensin II in various hypertensive disorders and body fluid abnormalities (author's transl)].
    Yamamoto T; Ogihara T; Kumahara Y; Hata T
    Nihon Naika Gakkai Zasshi; 1976; 65(5):464-70. PubMed ID: 988084
    [No Abstract]   [Full Text] [Related]  

  • 77. Prolonged treatment of high-renin hypertension with a converting enzyme inhibitor.
    Vandenburg MJ; Sharman VL; Marsh FP; Rucinska EJ
    Br Med J; 1978 Sep; 2(6141):866. PubMed ID: 709099
    [No Abstract]   [Full Text] [Related]  

  • 78. Letter: Saralasin bolus test.
    MacGregor GA; Dawes PM
    Lancet; 1975 Nov; 2(7941):923. PubMed ID: 53401
    [No Abstract]   [Full Text] [Related]  

  • 79. [Effect of Ileu5-angiotensin II on blood pressure and various adrenocortical steroids (author's transl)].
    Nigawara K; Furukawa T; Inatsumi H; Yagihbashi Y; Funyu T
    Horumon To Rinsho; 1980 Oct; 28(10):1191-6. PubMed ID: 7214726
    [No Abstract]   [Full Text] [Related]  

  • 80. [Specific covalent attachment of adrenocorticotropin and angiotensin II derivatives to polymeric matrices for use in affinity chromatography (author's transl)].
    Fauchère JL; Pelican GM
    Helv Chim Acta; 1975 Nov; 58(7):1984-94. PubMed ID: 172479
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.